Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Codiak BioSciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 52 | 56 | +4 |
| Shares | 14.0M | 13.7M | −337.9K (−2.4%) |
| Value | $259.9M | $223.6M | −$36.3M (−14.0%) |
New holders (7)
Institutions that held Codiak BioSciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 119,895 | $1.96M | 0.45% |
| Boothbay Fund Management, LLC | 12,082 | $197.0K | 0.01% |
| MetLife Investment Management | 6,809 | $111.2K | 0.00% |
| Metropolitan Life Insurance Co | 5,152 | $84.1K | 0.00% |
| Migdal Insurance & Financial Holdings Ltd. | 545 | $9.00K | 0.00% |
| Captrust Financial Advisors | 142 | $2.00K | 0.00% |
| Group One Trading, L.P. | 22 | $0 | 0.00% |
Sold out (3)
Institutions that held Codiak BioSciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Qube Research & Technologies Ltd | 11,584 | $215.0K |
| Virtu Financial LLC | 11,510 | $213.0K |
| Dynamic Technology Lab Private Ltd | 11,500 | $213.0K |